Human B cells localize and differentiate within the three dimensional architecture of lymphoid germinal centers (GC). The structural and cellular composition of the GC reflects its function, which is antigen driven B-cell proliferation and differentiation, and the generation of B cell memory. The GC provides a microenvironment in which activated B cells physically associate and interact with other cells including T and B lymphocytes, macrophages, and a cell which is unique to the GC--the follicular dendritic cell (FDC). Within this microenvironment, little is known about the mechanisms of cellular adhesion and the functional consequences of these interactions. Specifically, adhesion receptors have been demonstrated to play a central role in the regulation of the immune response. We have recently developed a frozen section GC binding assay which naturally reproduces the cellular interactions between human B cells and components of GCs in vivo. Using this assay, a receptor ligand pair (VLA-4:VCAM-1) was identified to be involved in the binding of normal and neoplastic B cells to FDCs within the GC. These studies suggested that although VLA4 is involved in binding, either qualitative changes in VLA-4 or additional structures are necessary to explain the binding of activated B cells to the GC. The objective of this proposal is to examine the adhesive interactions of normal and neoplastic B cells with the components of the GC.
The specific aims are: 1) To examine the role B cell activation on VLA-4 mediated adhesion to the GC; 2) To determine if VLA4 is involved in the regulation of B cell function; and 3) To identify other structures involved in B cell-GC binding. These studies will likely identify the structures which mediate cell-cell interactions within the GC. More importantly, the function of these adhesion receptors on B cells will be extensively studied and may provide insight into the regulation of B cell differentiation which occurs in the GC. These studies will not only be important in the understanding of normal B cell biology but will likely provide a foundation upon which to understand the biology of follicular non-Hodgkins lymphomas (NHL). Follicular lymphomas are the morphologic and phenotypic neoplastic counterparts of normal germinal center B cells. These tumor recapitulate the architecture of the normal GC and the neoplastic B cells employ VLA-4:VCAM-1 as one mechanism of malignant cell localization. Since virtually all of these tumors are widely disseminated at diagnosis, studies of normal and neoplastic GC microenvironments should provide a foundation upon which to understand the clinical presentation and course of this disease. Moreover, these studies may provide novel approaches with which to consider the regulation of the growth and dissemination of follicular NHLs and thereby suggesting new therapeutic approaches.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA055207-02
Application #
3199670
Study Section
Pathology B Study Section (PTHB)
Project Start
1991-07-08
Project End
1994-06-30
Budget Start
1992-07-01
Budget End
1993-06-30
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Husson, Herve; Carideo, Elizabeth G; Neuberg, Donna et al. (2002) Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays. Blood 99:282-9
Husson, H; Lugli, S M; Ghia, P et al. (2000) Functional effects of TNF and lymphotoxin alpha1beta2 on FDC-like cells. Cell Immunol 203:134-43
Grossbard, M L; Multani, P S; Freedman, A S et al. (1999) A Phase II study of adjuvant therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with relapsed B-cell non-Hodgkin's lymphoma. Clin Cancer Res 5:2392-8
Grossbard, M L; Fidias, P; Kinsella, J et al. (1998) Anti-B4-blocked ricin: a phase II trial of 7 day continuous infusion in patients with multiple myeloma. Br J Haematol 102:509-15
Ghia, P; Boussiotis, V A; Schultze, J L et al. (1998) Unbalanced expression of bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival. Blood 91:244-51
Astier, A; Manie, S N; Law, S F et al. (1997) Association of the Cas-like molecule HEF1 with CrkL following integrin and antigen receptor signaling in human B-cells: potential relevance to neoplastic lymphohematopoietic cells. Leuk Lymphoma 28:65-72
Astier, A; Avraham, H; Manie, S N et al. (1997) The related adhesion focal tyrosine kinase is tyrosine-phosphorylated after beta1-integrin stimulation in B cells and binds to p130cas. J Biol Chem 272:228-32
Astier, A; Manie, S N; Avraham, H et al. (1997) The related adhesion focal tyrosine kinase differentially phosphorylates p130Cas and the Cas-like protein, p105HEF1. J Biol Chem 272:19719-24
Manie, S N; Beck, A R; Astier, A et al. (1997) Involvement of p130(Cas) and p105(HEF1), a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cells. J Biol Chem 272:4230-6
Manie, S N; Sattler, M; Astier, A et al. (1997) Tyrosine phosphorylation of the product of the c-cbl protooncogene is [corrected] induced after integrin stimulation. Exp Hematol 25:45-50

Showing the most recent 10 out of 29 publications